Table 7.
Outcome measures | MMR+WEB (n=55) | MMR (n=44) | P value | Difference MMR+WEB–MMR | Effect size (d) | |||
|
Mean (SD) | Mean (SD) | Time*group | Time | Mean (95% CI) | P value |
|
|
ASES pain |
|
|
.04 | .28 |
|
|
|
|
|
Baseline | 45.8 (21.6) | 49.0 (20.4) |
|
|
|
|
|
|
4 months | 50.0 (23.4) | 49.3 (21.9) |
|
|
3.9 (–2.5 to 10.3) | .23 | 0.19 |
|
12 months | 53.2 (22.3) | 46.9 (22.2) |
|
|
9.5 (1.2 to 17.7) | .02 | 0.45 |
ASES other symptoms |
|
.89 | .01 |
|
|
|
||
|
Baseline | 52.6 (19.2) | 52.0 (16.7) |
|
|
|
|
|
|
4 months | 58.1 (21.5) | 56.1 (19.8) |
|
|
1.4 (–4.7 to 7.5) | .65 | 0.08 |
|
12 months | 57.5 (20.5) | 55.8 (21.8) |
|
|
1.2 (–6.7 to 9.0) | .78 | 0.06 |
GSEa |
|
|
.30 | .12 |
|
|
|
|
|
Baseline | 2.90 (0.60) | 2.97 (0.46) |
|
|
|
|
|
|
4 months | 2.88 (0.58) | 3.06 (0.53) |
|
|
–0.10 (–0.22 to 0.02) | .11 | –0.10 |
|
12 months | 2.93 (0.62) | 3.08 (0.56) |
|
|
–0.07 (–0.22 to 0.07) | .33 | –0.15 |
a MMR+WEB group (n=54) and MMR group (n=43).